Hoestdrank Noscapine Hcl Htp (Noscapine Hydrochloride)

Hoestdrank Noscapine Hcl Htp is primarily indicated for the symptomatic relief of cough associated with various respiratory conditions, and may be used as part of a broader supportive care plan.

• Acute, non‑productive cough caused by upper respiratory tract irritation.
• Cough associated with common cold or mild viral respiratory infections.
• Cough that interferes with sleep or daily activities in otherwise healthy adults.
• Adjunctive therapy for cough during recovery from minor bronchial irritation.
• Situations where a non‑opioid antitussive is preferred.

• Noscapine hydrochloride acts on the central nervous system to suppress the cough reflex. The compound is thought to modulate sigma‑1 receptors and other neuronal pathways involved in cough generation, reducing the sensitivity of the medullary cough center without producing significant analgesic or sedative effects. Its central action distinguishes it from peripheral antitussives that act on airway receptors. Its oral bioavailability allows systemic distribution to reach the brain in therapeutic concentrations.

Adverse reactions to Hoestdrank Noscapine Hcl Htp are generally mild, but rare serious events have been reported. These events are typically reversible after discontinuation of the product.

Common

• Nausea, stomach discomfort, or mild gastrointestinal upset.
• Dizziness, light‑headedness, or a brief feeling of vertigo.
• Transient headache that resolves without medication.
• Mild skin redness, itching, or localized rash.
• Dry mouth or mild taste disturbance.

Serious

• Allergic reactions including facial, lip, or tongue swelling (angioedema).
• Severe cutaneous reactions such as extensive rash, blistering, or Stevens‑Johnson‑like syndrome.
• Sudden drop in blood pressure leading to fainting or syncope.

Precautions should be considered before using Hoestdrank Noscapine Hcl Htp to ensure safe and appropriate use.

• Verify that the cough is non‑productive and not caused by a serious underlying condition.
• Use only under guidance if you have liver or kidney impairment, as metabolism may be altered.
• Avoid use in individuals with known hypersensitivity to noscapine or related compounds.
• Pregnant or breastfeeding persons should consult a healthcare professional before taking the product.
• Caution is advised when operating machinery or driving if dizziness occurs.
• Discontinue use and seek medical advice if the cough persists more than two weeks or worsens.

Hoestdrank Noscapine Hcl Htp may interact with other medicines, and certain combinations should be avoided or monitored closely.

Avoid

• Concurrent use with strong central nervous system depressants such as opioids or benzodiazepines, which may enhance sedative effects.
• Combination with monoamine oxidase inhibitors (MAOIs) or other cough suppressants that could increase risk of respiratory depression.

Use with caution

• Antihistamines or decongestants that may also cause dizziness; monitor for additive central effects.
• Medications metabolized by hepatic CYP enzymes, as noscapine may influence their clearance.
• Herbal products like St. John’s wort that induce CYP activity, potentially reducing noscapine effectiveness.